Cite
Japanese encephalitis vaccine for travelers: risk-benefit reconsidered.
MLA
Connor, Bradley A., et al. “Japanese Encephalitis Vaccine for Travelers: Risk-Benefit Reconsidered.” Journal of Travel Medicine, vol. 26, no. 5, Sept. 2019, pp. 1–3. EBSCOhost, https://doi.org/10.1093/jtm/taz037.
APA
Connor, B. A., Hamer, D. H., Kozarsky, P., Jong, E., Halstead, S. B., Keystone, J., Mileno, M. D., Dawood, R., Rogers, B., & Bunn, W. B. (2019). Japanese encephalitis vaccine for travelers: risk-benefit reconsidered. Journal of Travel Medicine, 26(5), 1–3. https://doi.org/10.1093/jtm/taz037
Chicago
Connor, Bradley A, Davidson H Hamer, Phyllis Kozarsky, Elaine Jong, Scott B Halstead, Jay Keystone, Maria D Mileno, Richard Dawood, Bonnie Rogers, and William B Bunn. 2019. “Japanese Encephalitis Vaccine for Travelers: Risk-Benefit Reconsidered.” Journal of Travel Medicine 26 (5): 1–3. doi:10.1093/jtm/taz037.